D-Index & Metrics Best Publications
Medicine
Israel
2022

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 119 Citations 54,978 1,220 World Ranking 1623 National Ranking 4

Research.com Recognitions

Awards & Achievements

2022 - Research.com Medicine in Israel Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Gene

His primary areas of study are Internal medicine, Transplantation, Immunology, Surgery and Gastroenterology. Internal medicine and Oncology are commonly linked in his work. His research investigates the link between Oncology and topics such as Lymphoma that cross with problems in Chimeric antigen receptor and Minimal residual disease.

His Transplantation research is multidisciplinary, incorporating elements of Hematology and Transplantation Conditioning. His study in Immunology is interdisciplinary in nature, drawing from both Stem cell and Cell biology. His study looks at the intersection of Gastroenterology and topics like Immunotherapy with Adoptive cell transfer.

His most cited work include:

  • Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases (1962 citations)
  • The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. (720 citations)
  • Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression (547 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Internal medicine, Transplantation, Oncology, Immunology and Surgery. His Gastroenterology research extends to the thematically linked field of Internal medicine. The Transplantation study combines topics in areas such as Regimen, Stem cell, Cumulative incidence and Fludarabine.

His Oncology research includes themes of Retrospective cohort study, Chemotherapy and Multiple myeloma. His studies deal with areas such as Haematopoiesis and Cancer research as well as Immunology. His Hematopoietic stem cell transplantation study incorporates themes from Survival rate and Transplantation Conditioning.

He most often published in these fields:

  • Internal medicine (62.08%)
  • Transplantation (50.24%)
  • Oncology (30.26%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (62.08%)
  • Transplantation (50.24%)
  • Oncology (30.26%)

In recent papers he was focusing on the following fields of study:

Arnon Nagler mostly deals with Internal medicine, Transplantation, Oncology, Acute leukemia and Hematopoietic stem cell transplantation. The study of Internal medicine is intertwined with the study of Gastroenterology in a number of ways. His Transplantation research focuses on Incidence and how it connects with Multivariate analysis.

His research integrates issues of Refractory, Fludarabine, Multiple myeloma and Busulfan in his study of Oncology. His Hematopoietic stem cell transplantation research is multidisciplinary, incorporating perspectives in Survival rate, Human leukocyte antigen and Univariate analysis. His Graft-versus-host disease research incorporates themes from Anti-thymocyte globulin and Immunology.

Between 2017 and 2021, his most popular works were:

  • Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (99 citations)
  • Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial (84 citations)
  • Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report. (81 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Gene

Arnon Nagler focuses on Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Acute leukemia. His Internal medicine study frequently intersects with other fields, such as Gastroenterology. His work carried out in the field of Transplantation brings together such families of science as Hematology, Retrospective cohort study, Total body irradiation, Stem cell and Disease.

His biological study spans a wide range of topics, including Young adult, Regimen, Marrow transplantation, Cell therapy and Fludarabine. Arnon Nagler interconnects Survival rate, Transplantation Conditioning, Cumulative incidence and Intensive care medicine in the investigation of issues within Hematopoietic stem cell transplantation. As a part of the same scientific study, Arnon Nagler usually deals with the Acute leukemia, concentrating on Busulfan and frequently concerns with ThioTEPA.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

Shimon Slavin;Arnon Nagler;Ella Naparstek;Yossi Kapelushnik.
Blood (1998)

3223 Citations

The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice.

Amnon Peled;Orit Kollet;Tanya Ponomaryov;Isabelle Petit.
Blood (2000)

1124 Citations

Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression

Robert Z. Orlowski;Arnon Nagler;Pieter Sonneveld;Joan Bladé.
Journal of Clinical Oncology (2007)

846 Citations

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

Camille Abboud;Ellin Berman;Adam Cohen.
Blood (2013)

692 Citations

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT).

M. Aoudjhane;M. Labopin;N. C. Gorin;A. Shimoni.
Leukemia (2005)

581 Citations

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

Philippe Armand;Arnon Nagler;Edie A. Weller;Steven M. Devine.
Journal of Clinical Oncology (2013)

539 Citations

Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

Christoph Schmid;Myriam Labopin;Arnon Nagler;Martin Bornhäuser.
Journal of Clinical Oncology (2007)

525 Citations

Rapid and efficient homing of human CD34+CD38−/lowCXCR4+stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2mnull mice

Orit Kollet;Asaf Spiegel;Amnon Peled;Isabelle Petit.
Blood (2001)

458 Citations

CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice.

Sigal Tavor;Isabelle Petit;Svetlana Porozov;Abraham Avigdor;Abraham Avigdor.
Cancer Research (2004)

447 Citations

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Nicolaus Kröger;Ernst Holler;Guido Kobbe;Martin Bornhäuser.
Blood (2009)

412 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Arnon Nagler

Xiao-Jun Huang

Xiao-Jun Huang

Peking University

Publications: 241

Sergio Giralt

Sergio Giralt

Memorial Sloan Kettering Cancer Center

Publications: 189

Nicolaus Kröger

Nicolaus Kröger

Universität Hamburg

Publications: 173

Mohamad Mohty

Mohamad Mohty

Université Paris Cité

Publications: 163

Richard E. Champlin

Richard E. Champlin

The University of Texas MD Anderson Cancer Center

Publications: 155

Rainer Storb

Rainer Storb

Fred Hutchinson Cancer Research Center

Publications: 142

Brenda M. Sandmaier

Brenda M. Sandmaier

Fred Hutchinson Cancer Research Center

Publications: 137

Hillard M. Lazarus

Hillard M. Lazarus

Case Western Reserve University

Publications: 134

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 125

Jorge E. Cortes

Jorge E. Cortes

Augusta University

Publications: 122

Daniel J. Weisdorf

Daniel J. Weisdorf

University of Minnesota

Publications: 116

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 111

Dietger Niederwieser

Dietger Niederwieser

Leipzig University

Publications: 105

Gérard Socié

Gérard Socié

Université Paris Cité

Publications: 103

David G. Maloney

David G. Maloney

Fred Hutchinson Cancer Research Center

Publications: 101

Olle Ringdén

Olle Ringdén

Karolinska Institute

Publications: 100

Trending Scientists

Len Bass

Len Bass

Carnegie Mellon University

Yushu Zhang

Yushu Zhang

Nanjing University of Aeronautics and Astronautics

Wojciech Kujawski

Wojciech Kujawski

Nicolaus Copernicus University

S. Ramakrishnan

S. Ramakrishnan

Tata Institute of Fundamental Research

Zhi-Wei Shan

Zhi-Wei Shan

Xi'an Jiaotong University

Francis Gilbert

Francis Gilbert

University of Nottingham

Alicia J. Kowaltowski

Alicia J. Kowaltowski

Universidade de São Paulo

Dario Leister

Dario Leister

Ludwig-Maximilians-Universität München

Jun Ichi Abe

Jun Ichi Abe

The University of Texas MD Anderson Cancer Center

Michael C. Thorndyke

Michael C. Thorndyke

Royal Swedish Academy of Sciences

Thomas Bjarnsholt

Thomas Bjarnsholt

University of Copenhagen

Bryan D. Harrison

Bryan D. Harrison

James Hutton Institute

Matthew P. Golombek

Matthew P. Golombek

California Institute of Technology

Mark W. Claire

Mark W. Claire

University of St Andrews

Ivan Bièche

Ivan Bièche

Institute Curie

Peter Riederer

Peter Riederer

University of Würzburg

Something went wrong. Please try again later.